Insulet (NASDAQ: PODD) reported Q3 EPS of ($0.05), $0.04 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $94.9 million versus the consensus estimate of $89.75 million.

GUIDANCE:

Insulet sees FY2016 revenue of $362-365 million, versus prior guidance of $345-355 million and the consensus of $351.5 million.

For earnings history and earnings-related data on Insulet (PODD) click here.